XORTX Therapeutics Inc.
XRTX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 122.50K | -587.00K | 170.10K | -3.02M | 2.70M |
| Total Depreciation and Amortization | 26.10K | 25.90K | 33.00K | 32.10K | 24.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -762.90K | -247.50K | -1.60M | 2.01M | -3.61M |
| Change in Net Operating Assets | -272.20K | 56.70K | 659.20K | -326.90K | -412.20K |
| Cash from Operations | -886.40K | -751.90K | -736.50K | -1.30M | -1.30M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00K | -23.20K | -9.10K | -2.60K | -9.80K |
| Cash from Investing | -4.00K | -23.20K | -9.10K | -2.60K | -9.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -22.70K | -22.20K | -8.90K | -15.90K | -17.00K |
| Issuance of Common Stock | 1.50M | 0.00 | 0.00 | 2.02M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -370.30K | 0.00 | 0.00 | -297.60K | -295.30K |
| Cash from Financing | 1.11M | -22.20K | -8.90K | 1.70M | -312.30K |
| Foreign Exchange rate Adjustments | -43.70K | 19.50K | -2.50K | -9.30K | -1.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.90K | -777.70K | -757.00K | 387.80K | -1.62M |
